Cerus (CERS) Net Equity Issued and Repurchased (2010 - 2026)
Cerus (CERS) posted Net Equity Issued and Repurchased of -$55000.0 for Q2 2026, down 205.77% sequentially from $52000.0 in Q3 2025, and down 77.42% YoY from -$243571.4 in Q2 2025.
Cerus (CERS) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Cerus has reported Net Equity Issued and Repurchased for 17 years, with the latest figure at -$55000.0 in Q2 2026.
- Quarterly Net Equity Issued and Repurchased fell 77.42% year-over-year to -$55000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$3000.0 (up 98.11% YoY) and the FY2025 annual result came in at -$35000.0, up 74.45% from the prior year.
- Net Equity Issued and Repurchased retreated to -$55000.0 in Q2 2026 per CERS's latest filing, from $52000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $52000.0 in Q3 2022 and troughed at -$72000.0 in Q1 2023.
- A 5-year average of -$34333.3 and a median of -$48500.0 in 2024 frame the typical range for Net Equity Issued and Repurchased.
- The sharpest annual moves came in 2022 and 2025: Net Equity Issued and Repurchased slumped 102.0% in 2022, then soared 223.81% in 2025.
- Over 5 years, Net Equity Issued and Repurchased stood at -$62000.0 in 2022, then soared by 38.71% to -$38000.0 in 2023, then grew by 21.05% to -$30000.0 in 2024, then surged by 273.33% to $52000.0 in 2025, then slumped by 205.77% to -$55000.0 in 2026.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered -$55000.0, $52000.0, and -$31000.0 for Q2 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | -55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -55,000.00 |
| Jun 30, 2026 | -55,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | -31,000.00 |
| Jun 30, 2025 | -31,000.00 |
| Mar 31, 2025 | -56,000.00 |
| Mar 31, 2025 | -56,000.00 |
| Dec 31, 2024 | -30,000.00 |
| Dec 31, 2024 | -30,000.00 |
| Sep 30, 2024 | -42,000.00 |
| Sep 30, 2024 | -42,000.00 |
| Jun 30, 2024 | -65,000.00 |
| Jun 30, 2024 | -65,000.00 |
| Dec 31, 2023 | -38,000.00 |
| Dec 31, 2023 | -38,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Jun 30, 2023 | -65,000.00 |
| Mar 31, 2023 | -72,000.00 |
| Mar 31, 2023 | -72,000.00 |